Quest Diagnostics 2015 Annual Report Download - page 43

Download and view the complete annual report

Please find page 43 of the 2015 Quest Diagnostics annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 129

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129

39
(w) Difficulties and uncertainties in the discovery, development, regulatory environment and/or marketing of new
services or solutions or new uses of existing tests.
(x) Failure to adapt to changes in the healthcare system and healthcare delivery, including those stemming from the
2010 federal healthcare reform legislation.
(y) Results and consequences of governmental inquiries.
(z) Trends in utilization of the healthcare system.
(aa) Increased patient financial responsibility for services.
(bb) Difficulty in implementing, or lack of success with, our strategic plan.
(cc) Inability to adapt to diverse and dynamic non-U.S. markets.
(dd) The impact of informatics on our industry and the ability of our Company to adapt to that impact.
Item 1B. Unresolved Staff Comments
There are no unresolved SEC comments that require disclosure.
Item 2. Properties
Our executive offices are located in Madison, New Jersey. We maintain clinical testing laboratories throughout the
continental United States; in several instances a joint venture of which we are a partner maintains the laboratory. We also
maintain offices, data centers, billing centers, call centers, distribution centers and patient service centers at locations
throughout the United States. In addition, we maintain offices, patient service centers and clinical laboratories in locations
outside the United States, including in Puerto Rico, Mexico, India and Ireland. Our properties that are not owned are leased on
terms and for durations that are reflective of commercial standards in the communities where these properties are located. We
believe that, in general, our facilities are suitable and adequate for our current and anticipated future levels of operation and are
adequately maintained. We believe that if we were unable to renew a lease on any of our facilities, we could find alternative
space at competitive market rates and relocate our operations to such new location without material disruption to our business.
Several of our principal facilities are highlighted below.
Location Leased or Owned
Sacramento, California (laboratory) Leased
West Hills, California (laboratory) Leased
San Juan Capistrano, California (laboratory) Owned
Tampa, Florida (laboratory) Owned
Atlanta, Georgia (laboratory) Owned
Chicago, Illinois (2) (laboratories) One owned, one leased
Marlborough, Massachusetts (laboratories) Leased
Baltimore, Maryland (laboratory) Owned
Teterboro, New Jersey (laboratory) Owned
Philadelphia, Pennsylvania (laboratory) Leased
Norristown, Pennsylvania (offices) Leased
Dallas, Texas (laboratory) Leased
Chantilly, Virginia (laboratory) Leased
Lenexa, Kansas (laboratory) Owned
Greensboro, North Carolina (laboratory) Leased
Item 3. Legal Proceedings
See Note 17 to the Consolidated Financial Statements (Part II, Item 8 of this Report) for information regarding legal
proceedings in which we are involved.
Item 4. Mine Safety Disclosures
Not applicable.
QUEST DIAGNOSTICS 2015 ANNUAL REPORT ON FORM 10-K